⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL240128 | 0.97 | — | — | |
| SCHEMBL5426968 | 0.97 | — | — | |
| SCHEMBL5438594 | 0.97 | — | — | |
| SCHEMBL8841873 | 0.97 | — | — | |
| SCHEMBL1071786 | 0.93 | — | — | |
| SCHEMBL8842231 | 0.93 | — | — | |
| SCHEMBL525562 | 0.93 | — | — | |
| SCHEMBL347410 | 0.93 | — | — | |
| SCHEMBL5686296 | 0.93 | — | — | |
| SCHEMBL204465 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230364222-A1 | RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS | DEVACELL, INC. | 2023-11-16 | — | — | US | claimed |
| WO-2022076756-A1 | RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS | DEVACELL, INC. (US) | 2022-04-14 | — | — | WO | claimed |
| US-20240026305-A1 | RECOMBINANT ONCOLYTIC VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS | DEVACELL, INC. | 2024-01-25 | — | — | US | disclosed |
| US-20230364222-A1 | RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS | DEVACELL, INC. | 2023-11-16 | — | — | US | disclosed |
| WO-2022109503-A1 | RECOMBINANT ONCOLYTIC VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS | DEVACELL, INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022076756-A1 | RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS | DEVACELL, INC. (US) | 2022-04-14 | — | — | WO | disclosed |
| US-9958446-B2 | Method for treatment of blood tumor using anti-TIM-3 antibody | KYOWA HAKKO KIRIN CO., LTD (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9540441-B2 | Polynucleotide encoding antibody to human IL-3 receptor alpha chain | KYOWA HAKKO KIRIN CO., LTD (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20160363595-A1 | METHOD FOR TREATMENT OF BLOOD TUMOR USING ANTI-TIM-3 ANTIBODY | KYOWA HAKKO KIRIN CO., LTD (JP) | 2016-12-15 | — | — | US | disclosed |
| US-9487591-B2 | Method for treatment of blood tumor using anti-TIM-3 antibody | KYOWA HAKKO KIRIN CO., LTD (JP) | 2016-11-08 | — | — | US | disclosed |
| US-20160280792-A1 | ANTIBODY TO HUMAN IL-3 RECEPTOR ALPHA CHAIN | KYOWA HAKKO KIRIN CO., LTD (JP) | 2016-09-29 | — | — | US | disclosed |
| US-9103832-B2 | Method for treatment of blood tumor using anti-TIM-3 antibody | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2015-08-11 | — | — | US | disclosed |
| EP-2426148-B1 | ANTI-IL-3RA ANTIBODY FOR USE IN TREATMENT OF BLOOD TUMOR | KYOWA HAKKO KIRIN CO LTD (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-20140134639-A1 | METHOD FOR TREATMENT OF BLOOD TUMOR USING ANTI-TIM-3 ANTIBODY | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2014-05-15 | — | — | US | disclosed |
| US-20130295107-A1 | ANTIBODY TO HUMAN IL-3 RECEPTOR ALPHA CHAIN | KYOWA KIRIN CO., LTD. (JP) | 2013-11-07 | — | — | US | disclosed |
| US-8492119-B2 | Antibody to human IL-3 receptor alpha chain | KYOWA HAKKO KIRIN CO., LTD (JP) | 2013-07-23 | — | — | US | disclosed |
| US-8480662-B2 | Systems and devices for photoablation | CARDIAC PACEMAKERS, INC. (US) | 2013-07-09 | — | — | US | disclosed |
| US-20120070448-A1 | ANTI-IL-3RA ANTIBODY FOR USE IN TREATMENT OF BLOOD TUMOR | KYOWA HAKKO KIRIN CO., LTD (JP) | 2012-03-22 | — | — | US | disclosed |
| EP-2426148-A1 | ANTI-IL-3RA ANTIBODY FOR USE IN TREATMENT OF BLOOD TUMOR | Kyowa Hakko Kirin Co., Ltd. (JP) | 2012-03-07 | — | — | EP | disclosed |
| EP-2417984-A1 | METHOD FOR TREATMENT OF BLOOD TUMOR USING ANTI-TIM-3 ANTIBODY | Kyowa Hakko Kirin Co., Ltd. (JP) | 2012-02-15 | — | — | EP | disclosed |